Chitosan microparticles for oral bioavailability improvement of the hydrophobic drug curcumin

Pharmazie

Volumn 67, Issue 6, 2012, Pages 525-528

  Wan, Shuxin ^a   Sun, Yingqian ^a   Sun, Li ^a   Tan, Fengping ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CURCUMIN; TRIPOLYPHOSPHATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CROSS LINKING; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; IONIZATION; LIPOPHILICITY; MALE; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PROTON TRANSPORT; RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CESIUM; CHITOSAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-LINKING REAGENTS; CURCUMIN; DRUG COMPOUNDING; ELECTROCHEMISTRY; EXCIPIENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POLYPHOSPHATES; RATS; RATS, WISTAR;

EID: 84862537718     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1124     Document Type: Article

References (13)

1. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.
2. Cui J, Yu B, Zhao Y, Zhu WW, Li HL, Lou HX, Zhai GX (2009) Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 371: 148-155.
3. Das RK, Kasoju N, Bora U (2010) Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6: 153-160.
4. Huang JJ, Wigent RJ, Bentzley CM, Schwartz JB (2006) Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery: effect of drug loading on release kinetics. Int J Pharm 319: 44-54.
5. Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS (2002) Preparation and characterization of chitosan microparticle intended for controlled drug delivery. Int J Pharm 249: 165-174.
6. Komal RP, Vijay PS, Sunny RS, Navin RS (2011) Improvement of dissolution properties of lamotrigine by inclusion complexation and solid dispersion technique. Pharmazie 66: 119-123.
7. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK (2007) Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330: 155-163.
8. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNVR (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37: 223-230.
9. Shu XZ, Zhu KJ (2000) A novel approach to prepare tripolyphosphate/ chitosan complex beads for controlled release drug delivery. Int J Pharm 201: 51-58.
10. Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ohike A, Ibuki R, Higaki K, Kimura T (2005) Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Control Release 108: 386-395.
11. Tiyaboonchai W, Tungpradit W, Plianbangchang P (2007) Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 337: 299-306.
12. Yang MS, Cui FD, You BG,You J, Wang L, Zhang LQ, Kawashima Y (2004) A novel pH-dependent gradient-release delivery system for nitrendipine I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs. J Control Release 98: 219-229.
13. Zhou HY, Chen XG, Liu CS, Meng XH, Liu CG, Yu LJ (2006) Release characteristics of three model drugs from chitosan/cellulose acetate multimicrospheres. Biochem Eng J 31: 228-233.